Advertisement
Goal is to pinpoint therapeutic targets, improve risk prediction in an understudied population
How the new collaboration is improving patient outcomes
Largest-to-date evaluation of germline mutations in this population demonstrates the value of genetics evaluation and genetic testing
Artificial intelligence applied to clinical and genomic data improves accuracy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Meet the Director of Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology
Screening assay effective across all stages, can identify tissue of origin
Some of the first epidemiologic insights into brain disorders caused by de novo variants
Copy number variants may help predict clinical outcomes
12-year-old will likely avoid some future surgeries thanks to multidisciplinary expertise
A new tool for medication optimization in the older adult population
Advertisement
Advertisement